PROFILE |
 |
It makes perfect sense that OrthoLogic makes devices that stimulate the healing of damaged or degenerated bone. The company's products include the OL1000, a portable, noninvasive device that uses magnetic-field technology to stimulate bone growth, and the SpinaLogic, a similar device used in conjunction with spinal fusion surgery. OrthoLogic has decided to divest its continuous passive motion (CPM) business, which made rehabilitative products such as braces, splints, and other orthopedic devices. The company now plans to focus solely on its bone-growth stimulation products. It is also developing Chrysalin, a drug that accelerates the healing of broken bones.
COMPETITION |
 |
Biomet, Inc. (BMET)
Orthofix International N.V. (OFIX)
Stryker Corporation (SYK)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 90.10
1-Yr. Sales Growth: 8.3%
Employees: 581
Revenue per employee: $155,077.45
KEY PEOPLE |
 |
Thomas R. Trotter
CEO
Terry D. Meier
CFO
CONTACT INFO |
 |
1275 W. Washington St.
Tempe, AZ 85281
US
Phone: 602-286-5520
Fax: 602-286-5224
Online: Web Site
|